: Halo Therapeutics stock drops following weak 2023 outlook
Halozyme Therapeutics Inc. HALO stock fell in the extended session Tuesday after the biotech drug maker’s 2023 forecast disappointed Wall Street. Halozyme shares fell as...
Jim Cramer’s 5 rules for earnings season
Jim Cramer gave his top rules for investors ahead of the upcoming earnings season.
Washington Watch: The Republican House sets up a committee on ‘the weaponization of the federal government’ — and terminates these panels
Republican lawmakers are establishing new committees now that they have control of the House of Representatives, while other panels are ending or changing.
The Ratings Game: Could Apple WiFi chips just be a ploy to get a better deal from Broadcom?
Broadcom shares fell on reports that Apple was working on its own RF chips, but one analyst wondered if it was all a negotiating ploy.
: Wells Fargo, once a mortgage giant, shrinks home-lending business
Wells Fargo said late Tuesday it was shrinking its home-mortgage business, aiming to serve its own bank customers as well as people in "minority communities."
: Pay ranges aren’t too ‘ridiculous’ as transparency laws take effect, report finds
Pay ranges being disclosed because of new laws appear to be potentially helpful despite early reports of ranges that are too wide, according to a...
HPE appoints former Pfizer CFO D’Amelio to board
Hewlett Packard Enterprise Co. on Tuesday appointed Frank D'Amelio, former chief financial officer of Pfizer Inc. , to HPE's board of directors. D'Amelio has more...
: Tandem Diabetes stock rises after preliminary sales hit reduced guidance, 2023 forecast exceeds mark
Tandem Diabetes Inc. TNDMshares gained nearly 7% in after-hours trading Tuesday, following preliminary quarterly sales information that lived up to reduced guidance from the company....